Jaguar LAA Acquires Laminar Program Assets from Johnson & Johnson
Newly formed medical device company Jaguar LAA acquired assets of the Laminar left atrial appendage closure program from Johnson & Johnson; terms undisclosed.
Read the full coverage, free
We only link to sources you can read without a subscription. How we check.